| Serial Number | 87322937 |
| Word Mark | REPLIMUNE |
| Filing Date | Thursday, February 2, 2017 |
| Status | 705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED |
| Status Date | Monday, August 26, 2024 |
| Registration Number | 5353768 |
| Registration Date | Tuesday, December 12, 2017 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 26, 2017 |
| Certificate of Correction for Registration | In the statement, "REG. NO. UK0000320659" should be deleted, and UK0003206593 should be inserted. |
| Goods and Services | Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; viruses for the treatment of cancer and tumors; viruses for inducing immune response for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceutical preparations and pharmaceutical substances for the treatment of [ infectious, ]oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceutical preparations and pharmaceutical substances used for the prevention and treatment of cancer and tumors; pharmaceuticals, namely, [ anti-infectives ] for the treatment of cancer, tumors, [ infectious, ] oncological, [ autoimmune, and immune system ] diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response for the treatment of cancer and tumors; vaccines; immunotherapy products, namely, pharmaceuticals for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system ] diseases and disorders |
| Goods and Services | [ Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services regarding research and development in the fields of pharmaceuticals, vaccines and medicines ] |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Monday, August 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 7, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Replimune Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RQ GB |
| Party Name | Replimune Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RQ GB |
| Party Name | Replimune Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RQ GB |
| Event Date | Event Description |
| Thursday, May 4, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, February 6, 2017 | NEW APPLICATION ENTERED |
| Tuesday, February 7, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 27, 2017 | ASSIGNED TO EXAMINER |
| Thursday, May 4, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 4, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 11, 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 19, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 4, 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, August 4, 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, August 14, 2017 | ASSIGNED TO LIE |
| Monday, August 14, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 14, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 18, 2017 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Saturday, August 19, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 6, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 26, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 26, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 12, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 20, 2018 | TEAS SECTION 7 REQUEST RECEIVED |
| Wednesday, March 28, 2018 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, April 11, 2018 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| Monday, September 10, 2018 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Thursday, September 20, 2018 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Friday, September 4, 2020 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Wednesday, June 12, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, August 26, 2024 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Monday, August 26, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Wednesday, December 6, 2023 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, December 12, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |